NR4A1 and breast neoplasm: Also Willipinski-Stapelfeldt et al., [43] stained more than 2500 primary breast tumors and demonstrated that approximately 35% of hormone receptor negative tumors expressed vimentin but only 7% of hormone receptor positive tumors expressed vimentin.